Good afternoon readers! Today's blog post is devoted to a rare sarcoma, but one that is super important to recognize - it can often be mistaken for other things that are much more common. There are some graphic pictures in this post, so just be aware ahead of time! Also, I am involved in several … Continue reading Angiosarcomas – past, present and future!
EHE 360 overview slides
Really enjoyed participating in this incredible conference coordinated by the EHE Foundation. Videos of the conference are available here but I also wanted to post the slides for review if helpful! Really encouraging to see all of the work being done for this rare sarcoma. Customizing therapies for individual EHE patientsDownload
cancer vs. coronavirus
In the words of Gandalf the Grey, we are indeed living in times that have shaken us collectively to the core. While social distancing has certainly impacted all of us worldwide, the effects on cancer patients are particularly unsettling. Life in the era of coronavirus adds another layer of uncertainty and fear to an already … Continue reading cancer vs. coronavirus
Leiomyosarcoma Patient Program March 14th in Denver!
With the National LeioMyoSarcoma Foundation, we are excited here at University of Colorado to host our first ever Leiomyosarcoma Patient Program. Come and join us to learn from our sarcoma experts. Program focusing on the latest and most exciting research available, as well as patient and caregiver breakout sessions with our fabulous supportive care team. … Continue reading Leiomyosarcoma Patient Program March 14th in Denver!
Intro to EHE: slides from Spectrum 2020
Spectrum 2020 Overview of EHEDownload By popular request - slides from my recent talk at Spectrum 2020, a meeting for interventional radiologists. let me know any questions!
Shining the Spotlight on Synovial Sarcoma…
Greetings readers! Today, the goal is to update you on some very exciting data that was recently presented at ESMO, the European Society of Medical Oncology Annual Meeting. In a nutshell, early results from a trial using a type of immune therapy called engineered T cells specific for a protein called MAGE-A4 led to significant tumor shrinkage in patients with … Continue reading Shining the Spotlight on Synovial Sarcoma…
New Video: Empowering the immune system in sarcomas
Greetings readers! This week I gave a talk at our Cancer Center's symposium series on some of the research that we're developing in the lab and in clinic on improving outcomes with immunotherapy in sarcomas. It's long and pretty scientific-focused, but reviews the major immunotherapy trials for sarcomas, and talks about ideas about how to … Continue reading New Video: Empowering the immune system in sarcomas
Updates from ASCO – 2019
Greetings loyal readers! I know it’s been a long time – as many of you may know, a few months ago I made the decision to move from University of Miami to the University of Colorado, and so it has been a busy, stressful, but invigorating process to reestablish myself in a new role! Unfortunately … Continue reading Updates from ASCO – 2019
ASCO 2018 Updates for Sarcomas
Dear readers, Just having returned from a particularly exhilarating annual ASCO meeting, I wanted to quickly share some of the most exciting results from the sarcoma sessions with all of you. Overall, this year revealed exciting advances in treatment of desmoid tumors, as well as PVNS. Additionally, we learned some important information about oral chemotherapy … Continue reading ASCO 2018 Updates for Sarcomas
Leiomyosarcoma in 2018 – where we are and where we need to go.
Good afternoon readers! Having recently teamed up with the National Leiomyosarcoma Foundation as an advisory board member, for this posting I thought we'd focus on leiomyosarcoma, including some of the most common questions coming in from patients, caretakers and providers. What is leiomyosarcoma? Leiomyosarcoma is probably the fourth most common sarcoma behind gastrointestinal stromal tumor (GIST), pleomorphic sarcomas, and liposarcomas. … Continue reading Leiomyosarcoma in 2018 – where we are and where we need to go.